Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Member Avatar bikesncats (20.26) Submitted: 15/07/2011 04:25:23 : Outperform Start Price: $4.92 KERX Score: +37.76

Phase 3 trials will show if this "lottery ticket" has what is takes to become a 10 bagger, I believe so.

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.